financetom
Business
financetom
/
Business
/
Keros Therapeutics voluntarily halts dosing of blood pressure treatment after safety review
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Keros Therapeutics voluntarily halts dosing of blood pressure treatment after safety review
Dec 12, 2024 3:52 AM

Dec 12 (Reuters) - Keros Therapeutics ( KROS ) said on

Thursday that it has voluntarily halted dosing of its 3.0

milligram (mg) and 4.5 mg doses of its high blood pressure

treatment in a mid-stage study based on a safety review.

(Reporting by Sneha S K; Editing by Abinaya Vijayaraghavan)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Digi Power X Reports Slight Drop in Cash, Bitcoin and Cash Deposits for April
Digi Power X Reports Slight Drop in Cash, Bitcoin and Cash Deposits for April
May 25, 2025
09:19 AM EDT, 05/01/2025 (MT Newswires) -- Digi Power X ( DGXX ) reported Thursday a slight decline in cash, Bitcoin and cash deposits in April compared to the previous month. The company held cash, Bitcoin (BTC) and cash deposits of about US$10.2 million as of April 30, compared with $10.3 million at the end of March. Digi Power said...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
ITT's Fiscal Q1 Adjusted Earnings, Revenue Rise
ITT's Fiscal Q1 Adjusted Earnings, Revenue Rise
May 25, 2025
09:19 AM EDT, 05/01/2025 (MT Newswires) -- ITT (ITT) reported fiscal Q1 adjusted earnings Thursday of $1.45 per diluted share, compared with $1.42 a year earlier. Analysts surveyed by FactSet expected $1.44. Revenue for the quarter ended March 29 was $913 million, compared with $910.6 million a year earlier. Analysts surveyed by FactSet expected $908.5 million. The company said it...
ATI Q1 Adjusted Earnings, Sales Rise; Q2 EPS Guidance Issued, 2025 EPS Outlook Raised
ATI Q1 Adjusted Earnings, Sales Rise; Q2 EPS Guidance Issued, 2025 EPS Outlook Raised
May 25, 2025
09:19 AM EDT, 05/01/2025 (MT Newswires) -- ATI (ATI) reported Q1 adjusted earnings Thursday of $0.72 per share, up from $0.48 a year earlier. Analysts polled by FactSet expected $0.59. Sales for the quarter ended March 30 were $1.14 billion, up from $1.04 billion a year earlier. Analysts surveyed by FactSet expected $1.09 billion. The company said it expects Q2...
Copyright 2023-2026 - www.financetom.com All Rights Reserved